KJHP
KRBP

K.J. Harrison & Partners’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

K.J. Harrison & Partners’s Portfolio KRBP Stock Details KRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,608
Closed -$41K – 332
2022
Q1 		$41K Buy
1,608
+734
+84% +$21.7K 0.01% 267
2021
Q4 		$40K Buy
874
+307
+54% +$20.9K 0.01% 317
2021
Q3 		$52K Buy
+567
New +$58.7K 0.01% 308

Other funds holding KRBP

ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

K.J. Harrison & Partners's KRBP Position: Q2 2022 in Review

K.J. Harrison & Partners sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q2 2022, closing a stake of 1,608 shares — an estimated $41K sold.

K.J. Harrison & Partners first reported a position in KRBP in Q3 2021 and held it in 3 quarters. The position peaked at $52K in Q3 2021. 17 funds tracked by Wall St. Rank hold KRBP as of Q2 2022.

  • K.J. Harrison & Partners reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • K.J. Harrison & Partners sold 1,608 Kiromic BioPharma, Inc. Common Stock shares in Q2 2022, an estimated $41K.
  • K.J. Harrison & Partners first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • K.J. Harrison & Partners's Kiromic BioPharma, Inc. Common Stock position peaked at $52K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q2 2022.

Based on K.J. Harrison & Partners's 13F filing for Q2 2022, filed 27 Jul 2022.